Terms: = Uterine cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132
20 results:
1. Oxidative Stress-regulating Enzymes and Endometrial cancer Survival in Relation to Metformin Intake in Diabetic Patients.
Kuusiniemi E; Karihtala P; Puistola U; Ahtikoski A; Urpilainen E
Anticancer Res; 2023 Dec; 43(12):5545-5554. PubMed ID: 38030210
[TBL] [Abstract] [Full Text] [Related]
2. Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma.
Li Y; McNally RP; Feng Y; Kim JJ; Wei JJ
Hum Reprod; 2023 Apr; 38(4):609-620. PubMed ID: 36749068
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the NRF2/keap1 pathway in cervical and endometrial cancers.
Tossetta G; Marzioni D
Eur J Pharmacol; 2023 Feb; 941():175503. PubMed ID: 36641100
[TBL] [Abstract] [Full Text] [Related]
4. Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and keap1 in Preeclampsia with and without Fetal Growth Restriction.
Mundal SB; Rakner JJ; Silva GB; Gierman LM; Austdal M; Basnet P; Elschot M; Bakke SS; Ostrop J; Thomsen LCV; Moses EK; Acharya G; Bjørge L; Iversen AC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216082
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of keap1 in cervical cancer.
Wang J; Li X; Zhou Y; Hong L
J BUON; 2021; 26(5):1809-1814. PubMed ID: 34761587
[TBL] [Abstract] [Full Text] [Related]
7. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
8. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A
Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
[TBL] [Abstract] [Full Text] [Related]
9. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
[TBL] [Abstract] [Full Text] [Related]
10. Cytoplasmic keap1 Expression Is Associated With Poor Prognosis in Endometrial cancer.
Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
[TBL] [Abstract] [Full Text] [Related]
11. A catalogue of somatic NRF2 gain-of-function mutations in cancer.
Kerins MJ; Ooi A
Sci Rep; 2018 Aug; 8(1):12846. PubMed ID: 30150714
[TBL] [Abstract] [Full Text] [Related]
12. keap1/NRF2 signaling pathway mutations in cervical cancer.
Chu XY; Li ZJ; Zheng ZW; Tao YL; Zou FX; Yang XF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4458-4466. PubMed ID: 30058679
[TBL] [Abstract] [Full Text] [Related]
13. Cigarette smoke extract and isoprene resulted in the induction of apoptosis and autophagy in human placenta choriocarcinoma JEG-3 cells.
Lee HM; Choi KC
Environ Toxicol; 2018 Feb; 33(2):178-190. PubMed ID: 29135079
[TBL] [Abstract] [Full Text] [Related]
14. Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1).
Sandhu IS; Maksim NJ; Amouzougan EA; Gallion BW; Raviele AL; Ooi A
Biochem Soc Trans; 2015 Aug; 43(4):650-6. PubMed ID: 26551707
[TBL] [Abstract] [Full Text] [Related]
15. Functional Role of NRF2 in Cervical Carcinogenesis.
Ma JQ; Tuersun H; Jiao SJ; Zheng JH; Xiao JB; Hasim A
PLoS One; 2015; 10(8):e0133876. PubMed ID: 26247201
[TBL] [Abstract] [Full Text] [Related]
16. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
Ooi A; Furge KA
Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
[TBL] [Abstract] [Full Text] [Related]
17. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
[TBL] [Abstract] [Full Text] [Related]
18. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.
Kim YR; Oh JE; Kim MS; Kang MR; Park SW; Han JY; Eom HS; Yoo NJ; Lee SH
J Pathol; 2010 Mar; 220(4):446-51. PubMed ID: 19967722
[TBL] [Abstract] [Full Text] [Related]
20. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.
Bachtiary B; Selzer E; Knocke TH; Pötter R; Obermair A
Cancer Lett; 2002 May; 179(2):197-203. PubMed ID: 11888674
[TBL] [Abstract] [Full Text] [Related]
